Robert F. Kennedy Jr.’s FDA Wish List: Raw Milk, Stem Cells, Heavy Metals
Published On Nov 12, 2024, 9:44 AM
Robert F. Kennedy Jr., serving as an adviser to President-elect Donald J. Trump on health matters, has openly criticized the FDA for its regulatory approach toward certain treatments. He has threatened to dismiss FDA employees involved in what he perceives as harmful actions against alternative health products and therapies. Kennedy's positions resonate particularly with conservative voters, emphasizing a focus on the issues surrounding ultraprocessed foods and unapproved medical treatments, including ivermectin and raw milk. Trump's support for Kennedy could suggest significant changes within public health policies, which may impact FDA operations.
Stock Forecasts
PFE
Negative
However, companies that rely on stringent FDA regulation to validate their products may face negative consequences as the FDA's authority is challenged. This includes mainstream pharmaceutical companies whose products might be eclipsed by alternatives promoted under the new regulatory environment.
Related News
Wall Street expects Trump presidency will unlock deal-making
Nov 7, 2024, 11:00 AM
Deal-making has slowed in recent years, largely due to high interest rates, soaring company valuations and a tight regulatory environment.
Why Businesses Worry About R.F.K. Jr.
Nov 1, 2024, 8:01 AM
The Kennedy scion has long been a skeptic of vaccines, pesticides and more. Corporate leaders worry he may gain policy power if Donald Trump wins.
As Election Looms, Disinformation ‘Has Never Been Worse’
Oct 23, 2024, 5:10 AM
A torrent of falsehoods, from home and abroad, have undermined what was once a shared faith in the honesty of America’s democracy.